Skip to main content

Home/ MaRS/ Group items tagged Ontario Cancer Institute

Rss Feed Group items tagged

Filter: All | Bookmarks | Topics Simple Middle
Assunta Krehl

Medical research innovator gets double honour - The Globe and Mail - April 7, 2010 - 0 views

www.theglobeandmail.com/...article1525630

Board Members Calvin Stiller MaRS Awards 2010 Canada Gairdner Award commercialization

shared by Assunta Krehl on 07 Apr 10 - Cached
  • Assunta Krehl on 07 Apr 10
     
    MD-entrepreneur Cal Stiller, noted for advocating commercial development of research, wins Gairdner Award and hall of fame berth. Dr. Calvin Stiller is the Chair of Ontario Institute for Cancer Research, Co-Founder and Board Member of MaRS Discovery District and past chair of Genome Canada.
Assunta Krehl

Gairdner winner urges need for greater Canadian medical research funding - Edmonton Jou... - 0 views

www.edmontonjournal.com/...story.html

Board Members Calvin Stiller Awards 2010 Canada Gairdner Award Commercialization

shared by Assunta Krehl on 07 Apr 10 - Cached
  • Assunta Krehl on 07 Apr 10
     
    Dr. Calvin Stiller, Chair of Ontario Institute for Cancer Research, Co-Founder and Board Member of MaRS Discovery District and past chair of Genome Canada is a recipient for the 2010 Canada Gairdner Award.
Assunta Krehl

DLVR Therapeutics Inc. Raises Additional Capital Adding MaRS Innovation to Investor Bas... - 0 views

www.prnewswire.com/...o-investor-base-132471363.html

Ontario Institute for Cancer Research OICR UHN University Health Network MaRS Innovation investing tenants

shared by Assunta Krehl on 29 Oct 11 - No Cached
  • Assunta Krehl on 29 Oct 11
     
    DLVR Therapeutics Inc. ("DLVR") - a privately-held biotechnology company announced it completed its seed round investment. University Health Network (UHN) and the Ontario Institute for Cancer Research (OICR) are investors in the company.
Assunta Krehl

Sprouter's demise a blow to startup community - The Globe and Mail - July 26, 2011 - 0 views

www.theglobeandmail.com/...article2110032.ece

MaRS Phase II tenants Ontario Institute for Cancer Research Public Health Ontario

shared by Assunta Krehl on 02 Sep 11 - No Cached
  • Assunta Krehl on 02 Sep 11
     
    MaRS Discovery District  announced that its Phase II construction and it is expected to be completed by 2013.
Assunta Krehl

BioRegion Newsmakers | BioRegion News | Bioregionnews | GenomeWeb - 0 views

www.genomeweb.com/...bioregion-newsmakers-20

Raphael Hofstein MaRS Innovation Ilse Treurnicht

shared by Assunta Krehl on 07 Aug 09 - Cached
  • Toronto's MaRS Innovation Names Raphael (Rafi) Hofstein President and CEO
  • Raphael (Rafi) Hofstein has been appointed the president and CEO of MaRS Innovation, a Toronto commercialization center for three universities, 10 academic teaching hospitals, and the Ontario Institute for Cancer Research.
  • He succeeds Ilse Treurnicht, who served as interim managing director of MaRS Innovation, and is CEO of MaRS Discovery District.
  • Assunta Krehl on 07 Aug 09
     
    Raphael (Rafi) Hofstein has been appointed the president and CEO of MaRS Innovation.
Assunta Krehl

Gairdner winner urges need for greater Canadian medical research funding - Vancouver Su... - 0 views

www.vancouversun.com/...story.html

Board Member Calvin Stiller Awards Canada Gairdner Award

shared by Assunta Krehl on 06 Apr 10 - Cached
  • Assunta Krehl on 06 Apr 10
     
    Dr. Calvin Stiller, Chair of Ontario Institute for Cancer Research, Board Member of MaRS Discovery District and past chair of Genome Canada is a recipient for the 2010 Canada Gairdner Award.
‹ Previous 21 - 26 of 26
Showing 20▼ items per page